After already halving its workforce twice since 2022, Sensei Therapeutics is forging ahead with another deep round of cuts. The biotech on Friday said 65% of its staffers are set to leave the company.

Sensei Biotherapeutics is abandoning its sole clinical-stage drug and warning of imminent layoffs as the company mulls its options. Two weeks ago, the biotech reported phase 1/2 data for its ...

BOSTON - Sensei Biotherapeutics, Inc. (NASDAQ:SNSE) announced Thursday it will discontinue development of its cancer drug solnerstotug and initiate a strategic review to maximize shareholder value.

BOSTON, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical-stage biotechnology company focused on the discovery and development of next-generation therapeutics ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Los Angeles-based Sensei was ...

One of the world’s richest men is expanding his investments in Central Texas. Sensei Farms, the agriculture company backed by Oracle Corp. co-founder, Chairman and Chief Technology Officer Larry ...

Travelers are chasing more than rest; they want lasting vitality. Alexandra Walterspiel is betting that the future of luxury lies in wellness, and her approach at Sensei hints at where high-end ...

BOSTON, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology company focused on the discovery and development of next-generation therapeutics ...

All the Latest Game Footage and Images from Sensei! I Like You So Much! Sensei! I Like You So Much! is a fangirl simulator. Step into the shoes of a passionate fan girl and embark on a journey through ...

Comedy and horror shouldn’t go together so well, but Hell Teacher: Jigoku Sensei Nube looks like it’ll do that and more, with the upcoming anime series set to release in July. The series follows ...